skip to content
Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992. Preview this item
ClosePreview this item
Checking...

Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Publisher: Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Online version:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Granting additional market exclusivity to the drug Ansaid.
Washington : U.S.G.P.O. : For sale by the U.S.G.P.O., Supt. of Docs., Congressional Sales Office, 1992
(OCoLC)648370840
Material Type: Government publication, National government publication, Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
ISBN: 0160383773 9780160383779
OCLC Number: 26019075
Notes: Item 1019-A, 1019-B (MF).
Distributed to some depository libraries in microfiche.
Shipping list no.: 92-0324-P.
"Serial no. 102-99."
Description: iii, 66 pages ; 24 cm

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/26019075> # Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "26019075" ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/28594269#Place/washington> ; # Washington
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
   schema:about <http://id.loc.gov/authorities/subjects/sh2008109173> ; # Pharmaceutical policy--United States
   schema:about <http://id.worldcat.org/fast/1060194> ; # Pharmaceutical policy
   schema:about <http://id.worldcat.org/fast/1054820> ; # Patent extensions
   schema:about <http://viaf.org/viaf/267042483> ; # Upjohn Company.
   schema:about <http://id.loc.gov/authorities/subjects/sh2010105216> ; # Patent extensions--United States
   schema:about <http://dewey.info/class/381.456157/e20/> ;
   schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
   schema:about <http://id.worldcat.org/fast/928203> ; # Flurbiprofen
   schema:about <http://id.loc.gov/authorities/classification/KF27> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/28594269#Organization/upjohn_company> ; # Upjohn Company.
   schema:bookFormat bgn:PrintBook ;
   schema:creator <http://viaf.org/viaf/150107916> ; # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
   schema:datePublished "1992" ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/28594269> ;
   schema:genre "Government publication"@en ;
   schema:genre "National government publication"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/648370840> ;
   schema:name "Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992."@en ;
   schema:productID "26019075" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/26019075#PublicationEvent/washington_u_s_g_p_o_for_sale_by_the_u_s_g_p_o_supt_of_docs_congressional_sales_office_1992> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/28594269#Agent/for_sale_by_the_u_s_g_p_o_supt_of_docs_congressional_sales_office> ; # For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
   schema:publisher <http://experiment.worldcat.org/entity/work/data/28594269#Agent/u_s_g_p_o> ; # U.S. G.P.O.
   schema:url <http://hdl.loc.gov/loc.law/llconghear.00185454411> ;
   schema:workExample <http://worldcat.org/isbn/9780160383779> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/26019075> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/28594269#Agent/for_sale_by_the_u_s_g_p_o_supt_of_docs_congressional_sales_office> # For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
    a bgn:Agent ;
   schema:name "For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office" ;
    .

<http://id.loc.gov/authorities/subjects/sh2008109173> # Pharmaceutical policy--United States
    a schema:Intangible ;
   schema:name "Pharmaceutical policy--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2010105216> # Patent extensions--United States
    a schema:Intangible ;
   schema:name "Patent extensions--United States"@en ;
    .

<http://id.worldcat.org/fast/1054820> # Patent extensions
    a schema:Intangible ;
   schema:name "Patent extensions"@en ;
    .

<http://id.worldcat.org/fast/1060194> # Pharmaceutical policy
    a schema:Intangible ;
   schema:name "Pharmaceutical policy"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
   schema:name "United States." ;
    .

<http://id.worldcat.org/fast/928203> # Flurbiprofen
    a schema:Intangible ;
   schema:name "Flurbiprofen"@en ;
    .

<http://viaf.org/viaf/150107916> # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
    a schema:Organization ;
   schema:name "United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment." ;
    .

<http://viaf.org/viaf/267042483> # Upjohn Company.
    a schema:Organization ;
   schema:name "Upjohn Company." ;
    .

<http://worldcat.org/isbn/9780160383779>
    a schema:ProductModel ;
   schema:isbn "0160383773" ;
   schema:isbn "9780160383779" ;
    .

<http://www.worldcat.org/oclc/648370840>
    a schema:CreativeWork ;
   rdfs:label "Granting additional market exclusivity to the drug Ansaid." ;
   schema:description "Online version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/26019075> ; # Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.
    .

<http://www.worldcat.org/title/-/oclc/26019075>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/26019075> ; # Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.
   schema:dateModified "2017-12-23" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.